| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.061 | 0.4 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.4 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.4 |